IQIRVO 80 MG
ELAFIBRANOR : 80 MG · DIN 02557010 · IPSEN BIOPHARMACEUTICALS CANADA INC
Health Canada status: MARKETED
What is IQIRVO?
IQIRVO 80 MG contains ELAFIBRANOR : 80 MG. It is listed in the Health Canada Drug Product Database under DIN 02557010, held by IPSEN BIOPHARMACEUTICALS CANADA INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 20-May-2025. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is IQIRVO used for?
IQIRVO® (elafibranor) is indicated for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA, or as monotherapy in adults unable to tolerate UDCA.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02557010 |
|---|---|
| Brand name | IQIRVO |
| Generic / active ingredient | ELAFIBRANOR : 80 MG |
| Manufacturer | IPSEN BIOPHARMACEUTICALS CANADA INC |
| Strength | 80 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | A05AX06 ELAFIBRANOR |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 20-May-2025 |
How is it stored and handled?
null
How is it supplied?
Each bottle contains 30 film-coated tablets.
Who else supplies ELAFIBRANOR worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. ELAFIBRANOR appears in 10 registered pack listings across 8 markets, published on 7 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.